Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): Moderate/severe versus mild stage of COPD

Scandinavian Journal of Immunology

Volumn 66, Issue 6, 2007, Pages 694-702

  Marc, M M ^a   Korosec, P ^a   Kern, I ^a   Sok, M ^b   Ihan, A ^c   Kosnik, M ^a  

^a UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CELL DIFFERENTIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG RESECTION; LYMPHOCYTIC INFILTRATION; MALE; PHENOTYPE; PRIORITY JOURNAL;

ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL;

EID: 36248946049     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.02018.x     Document Type: Article

References (63)

1. Flatcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977 1 : 1645 8.
2. Siafakas NM, Tzortzaki EG. Few smokers develop COPD. Why? Respir Med 2002 96 : 615 24.
3. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001 163 : 1304 9.
4. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001 17 : 946 53.
5. + T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 157 (3 Pt 1 822 6.
6. 1. Am J Respir Crit Care Med 1997 155 : 852 7.
7. Cosio MG, Majo J, Cosio MG. Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest 2002 121 (5 Suppl. 160S 5S.
8. Saetta M, Turato G, Baraldo S et al. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med 2000 161 (3 Pt 1 1016 21.
9. Turato G, Zuin R, Miniati M et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med 2002 166 : 105 10.
10. Saetta M, Baraldo S, Corbino L et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999 160 : 711 7.
11. Peinado VI, Barbera JA, Abate P et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999 159 (5 Pt 1 1605 11.
12. Retamales I, Elliott WM, Meshi B et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001 164 : 469 73.
13. Saetta M, Di Stefano A, Maestrelli P et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993 147 : 301 6.
14. Di Stefano A, Capelli A, Lusuardi M et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998 158 : 1277 85.
15. Andersson A, Qvarfordt I, Laan M et al. Impact of tobaco smoke on interleukin-16 protein in human airways, lymphoid tissue and T lymphocytes. Clin Exp Immunol 2004 138 : 75 82.
16. Hogg JC, Chu F, Utokaparch S et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004 350 : 2635 7.
17. Hayashi S. Latent adenovirus infection in COPD. Chest 2002 121 : 183S 7S.
18. Hogg JC. Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2001 164 : S71 5.
19. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995 152 : 1666 72.
20. Schumacher K, Haensch W, Roefzaad C, Schlag PM. Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res 2001 61 : 3932 6.
21. Zhang L, Conejo-Garcia JR, Katsaros D et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003 348 : 203 13.
22. Eerola AK, Soini Y, Paakko P. A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma. Clin Cancer Res 2000 6 : 1875 81.
23. Clark WH Jr., Elder DE, Guerry D 4th et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989 81 : 1893 904.
24. Hutchinson GH, Heinemann D, Symes MO, Williamson RC. Differential immune reactivity of tumour-intrinsic and peripheral-blood lymphocytes against autoplastic colorectal carcinoma cells. Br J Cancer 1981 44 : 396 402.
25. Miescher S, Whiteside TL, Carrel S, von Fliedner V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 1986 136 : 1899 907.
26. Totterman TH, Parthenais E, Hayry P, Timonen T, Saksela E. Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. III. Further functional investigations using cultured autochthonous tumor cell lines and freeze-thawed infiltrating inflammatory cells. Cell Immunol 1980 55 : 219 26.
27. Vose BM, Vanky F, Klein E. Human tumour-lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells. Int J Cancer 1977 20 : 895 902.
28. Ioannides CG, Whiteside TL. T cell recognition of human tumors: implications for molecular immunotherapy of cancer. Clin Immunol Immunopathol 1993 66 : 91 106.
29. Champagne P, Ogg GS, King AS et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001 410 106 11.
30. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002 8 : 379 85.
31. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001 163 : 1256 76.
32. + T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 2005 175 : 8218 25.
33. Aslan N, Yurdaydin C, Wiegand J et al. Cytotoxic CD4 T cells in viral hepatitis. J Viral Hepat 2006 13 : 505 14.
34. Zhu J, Majumdar S, Qiu Y et al. Interleukin-4 and interleukin-5 gene expression and inflammation in the mucus-secreting glands and subepithelial tissue of smokers with chronic bronchitis. Lack of relationship with CD8(+) cells. Am J Respir Crit Care Med 2001 164 : 2220 8.
35. Saetta M, Mariani M, Panina-Bordignon P et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002 165 : 1404 9.
36. Campbell JJ, Brightling CE, Symon FA et al. Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol 2001 166 : 2842 8.
37. Katchar K, Wahlstrom J, Eklund A, Grunewald J. Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis. Am J Respir Crit Care Med 2001 163 : 1540 5.
38. Ekberg-Jansson A, Andersson B, Avra E, Nilsson O, Lofdahl CG. The expression of lymphocyte surface antigens in bronchial biopsies, bronchoalveolar lavage cells and blood cells in healthy smoking and never-smoking men, 60 years old. Respir Med 2000 94 : 264 72.
39. +). Thorax 2003 58 : 23 9.
40. +T cells from a memory to memory/effector phenotype. J Immunol 2002 168 : 5538 50.
41. Majori M, Corradi M, Caminati A, Cacciani G, Bertacco S, Pesci A. Predominant TH1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease. J Allergy Clin Immunol 1999 103 (3 Pt 1 458 62.
42. Yoshino I, Yano T, Murata M et al. Phenotypes of lymphocytes infiltrating non-small cell lung cancer tissues and its variation with histological types of cancer. Lung Cancer 1993 10 : 13 9.
43. Riemann D, Wenzel K, Schulz T et al. Phenotypic analysis of T lymphocytes isolated from non-small-cell lung cancer. Int Arch Allergy Immunol 1997 114 : 38 45.
44. Ortegel JW, Staren ED, Faber LP, Warren WH, Braun DP. Cytokine biosynthesis by tumor-infiltrating T lymphocytes from human non-small-cell lung carcinoma. Cancer Immunol Immunother 2000 48 : 627 34.
45. Manna R, Cristiano G, Severino Martin L et al. Analysis of growth, phenotype and cytotoxic activity of tumor infiltrating lymphocytes expanded in vitro with interleukin-2 and interleukin-4: preliminary results. Ann Ital Med Int 1992 7 : 19 25.
46. Kemp RA, Ronchese F. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity. J Immunol 2001 167 : 6497 502.
47. Huang M, Wang J, Lee P et al. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res 1995 55 : 3847 53.
48. Viale M, Ferrini S, Serrano S, Serrano D, Ardizzoni A, Nicolin A. Peripheral blood and tumor infiltrating lymphocytes in non-small cell lung cancer: analysis at the population and clonal level. Tumori 1990 76 : 488 94.
49. Kataki A, Scheid P, Piet M et al. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. J Lab Clin Med 2002 140 : 320 8.
50. Domagala-Kulawik J, Guzman J, Costabel U. Immune cells in bronchoalveolar lavage in peripheral lung cancer - analysis of 140 cases. Respiration 2003 70 : 43 8.
51. Woo EY, Chu CS, Goletz TJ et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 2001 61 : 4766 72.
52. Woo EY, Yeh H, Chu CS et al. Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 2002 168 : 4272 6.
53. Liyanage UK, Moore TT, Joo HG et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002 169 : 2756 61.
54. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998 188 : 287 96.
55. Takeuchi T, Konno-Takahashi N, Kasuya Y, Ogushi T, Nishimatsu H, Kitamura T. Interleukin-2 blocks the antitumour activity caused by depletion of CD25 cells in a murine renal adenocarcinoma model. BJU Int 2004 94 : 171 6.
56. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000 101 : 455 8.
57. + T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients. Lung Cancer 2005 47 : 361 71.
58. + T cells infiltrating non-small cell lung cancer. Lung Cancer 2004 44 : 143 7.
59. + T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma. Cancer Res 2003 63 : 2535 45.
60. Yoshino I, Yano T, Murata M et al. Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor. Cancer Res 1992 52 : 775 81.
61. Swisher SG, Kiertscher SM, Golub SH, Holmes EC, Roth MD. Pulmonary macrophages suppress the proliferation and cytotoxicity of tumor-infiltrating lymphocytes. Am J Respir Cell Mol Biol 1993 8 : 486 92.
62. Weissler JC, Nicod LP, Toews GB. Pulmonary natural killer cell activity is reduced in patients with bronchogenic carcinoma. Am Rev Respir Dis 1987 135 : 1353 7.
63. Miyara M, Amoura Z, Parizot C et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006 203 : 359 70.